COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,870 Articles (22,568 medRxiv, 8,302 bioRxiv)

Most recent first Previous |  Page 2923: Articles 29221-29230  | Next

Do latitude and ozone concentration predict Covid-2019 cases in 34 countries?
Alipio, M. M.
10.1101/2020.04.09.20060202 — Posted: 2020-04-14
Covid-19 Testing, Hospital Admission, and Intensive Care Among 2,026,227 United States Veterans Aged 54-75 Years
Rentsch, C. T., Kidwai-Khan, F., Tate, J. P., Park, L. S., King, J. T., Skanderson, M., Hauser, R. G., Schultze, A., Jarvis, C. I., Holodniy, M., Lo Re, V., Akgun, K. M., Crothers, K., Taddei, T. H., Freiberg, M. S., Justice, A. C.
10.1101/2020.04.09.20059964 — Posted: 2020-04-14 Discussion: Onsite | Offsite
Hydroxychloroquine in patients with COVID-19: an open-label, randomized, controlled trial
Tang, W., Cao, Z., Han, M., Wang, Z., Chen, J., Sun, W., Wu, Y., Xiao, W., Liu, S., Chen, E., Chen, W., Wang, X., Yang, J., Lin, J., Zhao, Q., Yan, Y., Xie, Z., Li, D., Yang, Y., Liu, L., Qu, J., Ning, G., Shi, G., Xie, Q.
10.1101/2020.04.10.20060558 — Posted: 2020-04-14 Discussion: Onsite | Offsite
The first month of the COVID-19 outbreak in 46 sub-Saharan African countries; a comparative analysis of growth rates
Prince, M. J., Alem, A., Chibanda, D., Fairall, L., Fekadu, A., Hanlon, C., Lund, C., Leather, A. J., Petersen, I., Verhey, R., Wurie, H.
10.1101/2020.04.09.20057091 — Posted: 2020-04-14
Immunological assays for SARS-CoV-2: an analysis of available commercial tests to measure antigen and antibodies
Gonzalez, J. M., Shelton, J. W., Diaz-Vallejo, M., Rodriguez-Castellanos, V. E., Zuluaga, J. D. H., Chamorro, D. F., Arroyo-Ariza, D.
10.1101/2020.04.10.20061150 — Posted: 2020-04-14
Molecular mechanism of action of repurposed drugs and traditional Chinese medicine used for the treatment of patients infected with COVID-19: A systematic review
Lem, F. F., Opook, F., Herng, D. L. J., Na, C. S., Lawson, F. P., Tyng, C. F.
10.1101/2020.04.10.20060376 — Posted: 2020-04-14
A SIMPLE COLORIMETRIC MOLECULAR DETECTION OF NOVEL CORONAVIRUS (COVID-19), AN ESSENTIAL DIAGNOSTIC TOOL FOR PANDEMIC SCREENING
ANNAMALAI, P., KANTA, M., RAMU, P., RAVI, B., VEERAPANDIAN, K., SRINIVASAN, R.
10.1101/2020.04.10.20060293 — Posted: 2020-04-14
Multi-Stage Group Testing Optimizes COVID-19 Mass Population Testing
Eberhardt, J. N., Breuckmann, N. P., Eberhardt, C. S.
10.1101/2020.04.10.20061176 — Posted: 2020-04-14
Clinical features and management of severe COVID-19: A retrospective study in Wuxi, Jiangsu Province, China
Jiang, X., Tao, J., Wu, H., Wang, Y., Zhao, W., Zhou, M., Huang, J., You, Q., Meng, H., Zhu, F., Zhang, X., Qian, M., Qiu, Y.
10.1101/2020.04.10.20060335 — Posted: 2020-04-14
COVID-19 Global Pandemic Planning: Decontamination and Reuse Processes for N95 Respirators
Perkins, D. J., Villescas, S., Wu, T. H., Muller, T. B., Bradfute, S., Foo-Hurwitz, I., Cheng, Q., Wilcox, H., Weiss, M., Bartlett, C., Langsjoen, J., Seidenberg, P.
10.1101/2020.04.09.20060129 — Posted: 2020-04-14

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).